中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

52 records (took 0.034 seconds)

    항진균 활성을 갖는 트라이아졸 유도체, 이의 제조방법 및 이를 함유하는 약학 조성물
    31.
    发明公开
    항진균 활성을 갖는 트라이아졸 유도체, 이의 제조방법 및 이를 함유하는 약학 조성물 无效
    具有抗真菌活性的三唑衍生物，其制备方法和含有其的药物组合物

    公开(公告)号：KR1020090007675A

    公开(公告)日：2009-01-20

    申请号：KR1020080137288

    申请日：2008-12-30

    Applicant: 한국화학연구원 ,  주식회사 켐온

    Inventor： 김범태 ,  민용기 ,  허정녕 ,  이혁 ,  장성연 ,  박노균 ,  송시환 ,  오정자

    IPC: C07D401/14 ,  C07D417/14 ,  C07D413/14 ,  C07D513/04

    Abstract: A pharmaceutical composition comprising the triazole derivative having antifungal activity is provided to inhibit growth of various pathogenic bacteria, and reduce the toxicity compared to the conventional antifungal agent, thereby treating infection of fungus. The triazole derivative represented by the chemical formula(1) or pharmaceutically acceptable salts thereof have excellent antifungal activity, wherein n is 1 or 2; A indicates direct bonding or C=O; D is CH or N; Z is O or S; R2 is hydrogen, halogen, hydroxy, cyano, nitro, amino, hydroxy carbonyl, C1-6 alkyl, C2-6 alkenyl, C2-6 akynyl, C1-6 acyl, C1-6 acyloxy, heteroaryl-C1-6 alkyl amino or N-C1-6 alkyl N- heteroaryl-C1-6 alkyl amino; and R3 is phenyl and monocyclic heteroaryl, and is replaced by one radical selected from the group consisting of hydrogen, halogen, hydroxy, cyano, nitro, amino, hydroxy carbonyl, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, hydroxy C1-6 alkyl, C1-6 alkoxy C1-6 alkyl, perfluoro C1-6 alkyl and perfluoro C1-6 alkoxy.

    Abstract translation: 提供包含具有抗真菌活性的三唑衍生物的药物组合物，以抑制各种致病细菌的生长，并降低与常规抗真菌剂相比的毒性，从而治疗真菌的感染。 由化学式（1）表示的三唑衍生物或其药学上可接受的盐具有优异的抗真菌活性，其中n为1或2; A表示直接键合或C = O; D是CH或N; Z是O或S; R 2是氢，卤素，羟基，氰基，硝基，氨基，羟基羰基，C 1-6烷基，C 2-6烯基，C 2-6炔基，C 1-6酰基，C 1-6酰氧基，杂芳基-C 1-6烷基氨基或 N-C 1-6烷基N-杂芳基-C 1-6烷基氨基; 并且R 3是苯基和单环杂芳基，并被一个选自氢，卤素，羟基，氰基，硝基，氨基，羟基羰基，C 1-6烷基，C 2-6烯基，C 2-6炔基， C 1-6烷氧基，羟基C 1-6烷基，C 1-6烷氧基C 1-6烷基，全氟C 1-6烷基和全氟C 1-6烷氧基。

    β-아미노알콜 유도체를 포함하는 ＴＮＦ-α 매개성 질환의예방 또는 치료용 약학 조성물
    33.
    发明公开
    β-아미노알콜 유도체를 포함하는 ＴＮＦ-α 매개성 질환의예방 또는 치료용 약학 조성물 失效
    包含用于预防或治疗TNF-α的β型 - 氨基醇衍生物的药物组合物; 媒介疾病

    公开(公告)号：KR1020080048193A

    公开(公告)日：2008-06-02

    申请号：KR1020060118230

    申请日：2006-11-28

    Applicant: 한국화학연구원 ,  주식회사 오스코텍

    Inventor： 김범태 ,  민용기 ,  이혁 ,  허정녕 ,  장성연 ,  박노균 ,  이우길 ,  김성환 ,  김정근 ,  김세원 ,  고선일 ,  장순화

    IPC: A61K31/045 ,  A61P35/00

    CPC classification number: Y02A50/411

    Abstract: A beta-amino alcohol derivative is provided to show excellent TNF-alpha(tumor necrosis factor-alpha) inhibitory activity, thereby being used for a pharmaceutical composition for preventing or treating TNF-alpha mediated diseases. A composition for inhibiting TNF-alpha comprises a beta-amino alcohol derivative represented by a formula(1) or a pharmaceutically acceptable salt thereof as an active ingredient. In the formula(1), R^1 is phenyl substituted or unsubstituted by halogen; R^2 is pyridinyl, pyrimidinyl, indolyl or quinolyl substituted or unsubstituted by cyano or halogen; and R^3 is H or C1-4 alkyl. A pharmaceutical composition for preventing or treating TNF-alpha mediated diseases comprises the beta-amino alcohol derivative of the formula(1) or the pharmaceutically acceptable salt thereof.

    Abstract translation: 提供β-氨基醇衍生物以显示优异的TNF-α（肿瘤坏死因子-α）抑制活性，从而用于预防或治疗TNF-α介导的疾病的药物组合物。 用于抑制TNF-α的组合物包含由式（1）表示的β-氨基醇衍生物或其药学上可接受的盐作为活性成分。 在式（1）中，R 1是被卤素取代或未取代的苯基; R 2是被氰基或卤素取代或未取代的吡啶基，嘧啶基，吲哚基或喹啉基; R 3为H或C 1-4烷基。 用于预防或治疗TNF-α介导的疾病的药物组合物包含式（1）的β-氨基醇衍生物或其药学上可接受的盐。

    태양전지용 전극의 제조방법
    37.
    发明公开
    태양전지용 전극의 제조방법 有权
    太阳能电池电极的制造方法

    公开(公告)号：KR1020110119434A

    公开(公告)日：2011-11-02

    申请号：KR1020100039139

    申请日：2010-04-27

    Applicant: 한국과학기술연구원 ,  한국화학연구원

    Inventor： 장성연 ,  조성무 ,  김동영 ,  김준성 ,  윤성철

    IPC: H01L51/42 ,  H01L31/18

    CPC classification number: Y02E10/549 ,  Y02P70/521 ,  H01L51/42 ,  H01L31/18

    Abstract: PURPOSE: A method for manufacturing an electrode is provided to the manufacture a device with high crystallization by controlling the crystalline degree of a photoactive layer. CONSTITUTION: Spray solutions are made by solving electron donor organic material and electron acceptor organic material in a solvent. A photoactive layer is formed by electrically spraying spray solutions on a glass substrate with a transparent electrode. A mixing ratio of an electron donor organic material and an electron acceptor organic material is 9:1 or 1:9. The crystalline degree of the photoactive layer is controlled. A band gap of the electron donor organic material is 2.5 to 0.8 eV.

    Abstract translation: 目的：通过控制光活性层的结晶度，为制造具有高结晶度的装置提供电极制造方法。 构成：通过在溶剂中溶解电子给体有机材料和电子受体有机材料制成喷雾溶液。 通过在具有透明电极的玻璃基板上喷射喷雾溶液来形成光敏层。 电子给体有机材料和电子受体有机材料的混合比为9:1或1:9。 控制光敏层的结晶度。 电子给体有机材料的带隙为2.5至0.8eV。

    이소인돌리논 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
    38.
    发明公开
    이소인돌리논 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물 有权
    ISOINDOLINONE衍生物，其制备方法和包含其的药物组合物

    公开(公告)号：KR1020100123459A

    公开(公告)日：2010-11-24

    申请号：KR1020090042691

    申请日：2009-05-15

    Applicant: 한국화학연구원

    Inventor： 허정녕 ,  김범태 ,  이혁 ,  장성연 ,  이장희 ,  김성환 ,  류현모

    IPC: C07D209/46 ,  C07D209/44 ,  A61K31/4035 ,  A61P19/10

    Abstract: PURPOSE: An isoindolinone derivative and pharmaceutical composition containing the same are provided to enhance expression of alkaline phosphatase. CONSTITUTION: An insoindolinone derivative is denoted by chemical formula 1. A method for preparing the isoindolinone derivative comprises a step of amide-coupling phenylene diamine with a compound of chemical formula 8 to obtain an isoindolinone of chemical formula 2. In case of that one or more substituent R1-R4 in chemical formula 8 are halogen, the method further comprises a step of Suzuki-coupling boronic acid compound of chemical formula 17(RB(OH)_2) under the presence of palladium catalyst. A pharmaceutical composition for preventing or treating bone diseases contains the isoindolinone derivative of chemical formula 1 or pharmaceutically acceptable salt as an active ingredient.

    Abstract translation: 目的：提供异吲哚啉酮衍生物和含有它们的药物组合物，以增强碱性磷酸酶的表达。 构成：异吲哚啉酮衍生物由化学式1表示。制备异吲哚啉酮衍生物的方法包括将苯二胺与化学式8的化合物酰胺偶联以获得化学式2的异吲哚满酮的步骤。如果是那种或 化学式8中更多的取代基R 1 -R 4是卤素，该方法还包括在钯催化剂存在下的化学式17（RB（OH）2）的Suzuki-偶联硼酸化合物的步骤。 用于预防或治疗骨疾病的药物组合物含有化学式1的异吲哚啉酮衍生物或其药学上可接受的盐作为活性成分。

    벤조싸이아졸 유도체, 이의 제조 방법 및 이를 포함하는살균제 조성물
    39.
    发明授权
    벤조싸이아졸 유도체, 이의 제조 방법 및 이를 포함하는살균제 조성물 失效
    이이졸

    公开(公告)号：KR100929358B1

    公开(公告)日：2009-12-08

    申请号：KR1020080006333

    申请日：2008-01-21

    Applicant: 한국화학연구원 ,  주식회사경농

    Inventor： 허정녕 ,  김범태 ,  이혁 ,  장성연 ,  박노균 ,  장경수

    IPC: C07D277/82 ,  A01N43/78

    Abstract: A benzothiazole derivatives is provided to prevent the generation of drug resistance bacteria and improve the sterilization effect to plant late blight. A benzothiazole derivative is denoted by the chemical formula 1. In the chemical formula 1, X is H or C1-4 alkoxyl. The structure of Y is selected among structure formulas a, b, c, d, e, and f. The left side of Y is connected to N, the right side is connected to Z. R2 is H or C1-4 alkyl. Z is phenyl; phenyl which is substituted with one selected among halogen atom, cyano, methyl, nitro, phenyl, phenoxy, trifluoromethyl and hydroxyl, and isoxazole which is substituted with phenyl, chlorophenyl, or dichlorophenyl.

    Abstract translation: 提供苯并噻唑衍生物以防止产生耐药性细菌并提高杀死植物晚疫病的效果。 苯并噻唑衍生物由化学式1表示。在化学式1中，X是H或C1-4烷氧基。 Y的结构选自结构式a，b，c，d，e和f。 Y的左侧连接到N，右侧连接到Z.R2是H或C1-4烷基。 Z是苯基; 被选自卤原子，氰基，甲基，硝基，苯基，苯氧基，三氟甲基和羟基中的一个取代的苯基和被苯基，氯苯基或二氯苯基取代的异恶唑。

    2-이미노벤조이미다졸 유도체를 포함하는 살균제 조성물
    40.
    发明公开
    2-이미노벤조이미다졸 유도체를 포함하는 살균제 조성물 失效
    含有二氨基苯并咪唑衍生物的抗菌组合物

    公开(公告)号：KR1020090084502A

    公开(公告)日：2009-08-05

    申请号：KR1020080010723

    申请日：2008-02-01

    Applicant: 한국화학연구원 ,  주식회사경농

    Inventor： 김범태 ,  허정녕 ,  이혁 ,  장성연 ,  박노균 ,  최경자

    IPC: A01N43/50

    CPC classification number: A01N43/52 ,  A01N43/80 ,  A01N43/82 ,  C07D235/04 ,  C07D403/10 ,  C07D403/12 ,  C07D413/06

    Abstract: A germicide composition is provided to suppress the generation of drug-resistance bacteria using 2-iminobenzoimidazole derivative. A germicide composition comprises a 2-iminobenzoimidazole derivative of the chemical formula 1 as an active ingredient. In the chemical formula 1, R1 is C1-7 alkyl, C2-7 alkenyl, -CH2CH2NR^0(R^0 is diethyl or -CH2CH2OCH2CH2-) and benzyl which is not substituted or is substituted with one or more halogen or C1-3 alkyl. R2 is a phenyl which is not substituted or is substituted with one or more halogen atom, aryl or aryloxy, naphtyl, phenoxy methyl which is not substituted or is substituted with one or more halogen atom, C1-3 alkyl or C1-3 alkoxy, phenyl isoxazole which is not substituted or substituted with one or more halogen atom or 4-methyl-3-phenyl-1,2,4-oxadiazole-5(4H)-one.

    Abstract translation: 提供杀菌剂组合物以抑制使用2-亚氨基苯并咪唑衍生物产生耐药菌。 杀菌剂组合物包含化学式1的2-亚氨基苯并咪唑衍生物作为活性成分。 在化学式1中，R 1为C 1-7烷基，C 2-7烯基，-CH 2 CH 2 NR 2 O（R 10为二乙基或-CH 2 CH 2 OCH 2 CH 2 - ）和未被取代或被一个或多个卤素或C1- 3烷基。 R2是未被取代或被一个或多个卤素原子取代的苯基，未被取代或被一个或多个卤素原子取代的苯基甲基，芳基或芳氧基，苯基甲基，C 1-3烷基或C 1-3烷氧基， 未被一个或多个卤素原子取代或取代的苯基异恶唑或4-甲基-3-苯基-1,2,4-恶二唑-5（4H） - 酮。

Patent Agency Ranking